Endothelial function: From vascular biology to clinical applications

被引:391
作者
Behrendt, D [1 ]
Ganz, P [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
关键词
D O I
10.1016/S0002-9149(02)02963-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The endothelium, by releasing nitric oxide (NO), promotes vasodilation and inhibits inflammation, thrombosis, and vascular smooth muscle cell proliferation. These biological actions of NO make it an important component in the endogenous defense against atherosclerosis and its overt clinical complications. Loss of the functional integrity of the endothelium, as seen commonly in the milieu of cardiovascular risk factors, plays an integral role in all stages of atherosclerosis from lesion initiation to plaque rupture. A number of established techniques can assess endothelial function in human vascular beds. The outcome of endothelial testing has profound prognostic implications and is an independent predictor of atherosclerosis disease progression and cardiovascular event rates. The large clinical benefit of statins and angiotensin-converting enzyme inhibitors in patients with atherosclerosis involves favorable effects of endothelial function. Studies of endothelial function represent a prime example of a successful application of insights derived from vascular biology at the bedside. (C) 2002 by Excerpta Medica, Inc.
引用
收藏
页码:40L / 48L
页数:9
相关论文
共 111 条
[51]  
JOHNSONTIDEY RR, 1994, AM J PATHOL, V144, P952
[52]   IMPAIRED ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS [J].
JOHNSTONE, MT ;
CREAGER, SJ ;
SCALES, KM ;
CUSCO, JA ;
LEE, BK ;
CREAGER, MA .
CIRCULATION, 1993, 88 (06) :2510-2516
[53]   Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity [J].
Ju, H ;
Zou, R ;
Venema, VJ ;
Venema, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) :18522-18525
[54]   A HMG-CoA reductase inhibitor improved regression of atherosclerosis in the rabbit aorta without affecting serum lipid levels: Possible relevance of up-regulation of endothelial NO synthase mRNA [J].
Kano, H ;
Hayashi, T ;
Sumi, D ;
Esaki, T ;
Asai, Y ;
Thakur, NK ;
Jayachandran, M ;
Iguchi, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 259 (02) :414-419
[55]   Effects of cilazapril on vascular structure and function in essential hypertension [J].
Kiowski, W ;
Linder, L ;
Nuesch, R ;
Martina, B .
HYPERTENSION, 1996, 27 (03) :371-376
[56]   Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure [J].
Kojda, G ;
Harrison, D .
CARDIOVASCULAR RESEARCH, 1999, 43 (03) :562-571
[57]   NITRIC-OXIDE - AN ENDOGENOUS MODULATOR OF LEUKOCYTE ADHESION [J].
KUBES, P ;
SUZUKI, M ;
GRANGER, DN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) :4651-4655
[58]   LYSOPHOSPHATIDYLCHOLINE INHIBITS SURFACE RECEPTOR-MEDIATED INTRACELLULAR SIGNALS IN ENDOTHELIAL-CELLS BY A PATHWAY INVOLVING PROTEIN-KINASE-C ACTIVATION [J].
KUGIYAMA, K ;
OHGUSHI, M ;
SUGIYAMA, S ;
MUROHARA, T ;
FUKUNAGA, K ;
MIYAMOTO, E ;
YASUE, H .
CIRCULATION RESEARCH, 1992, 71 (06) :1422-1428
[59]   The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. [J].
Kureishi, Y ;
Luo, ZY ;
Shiojima, I ;
Bialik, A ;
Fulton, D ;
Lefer, DJ ;
Sessa, WC ;
Walsh, K .
NATURE MEDICINE, 2000, 6 (09) :1004-1010
[60]   Vascular extracellular superoxide dismutase activity in patients with coronary artery disease -: Relation to endothelium-dependent vasodilation [J].
Landmesser, U ;
Merten, R ;
Spiekermann, S ;
Büttner, K ;
Drexler, H ;
Hornig, B .
CIRCULATION, 2000, 101 (19) :2264-2270